-H-H Tai Researcher Activity Profile

Research Author Detailed Information 

H-H Tai Publication Rate By Year

H-H Tai has published 3 paper(s) in 2006, 10 paper(s) in 2007, for a total of 13 research publications in total.

H-H Hh Tai Author Information

LAST NAME: tai

FIRST NAME: H-H

INITIALS: hh

AFFILIATION:

Papers

H-H Tai's Publication Record

1. NAD+-linked 15-hydroxyprostaglandin dehydrogenase: structure and biological functions. Year Published: 2006
Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, 40536-0082, USA. htai1@uky.edu
2. Molecular dynamics simulation of cocaine binding with human butyrylcholinesterase and its mutants. Year Published: 2006
Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, Kentucky 40536, USA.
3. Reciprocal regulation of cyclooxygenase-2 and 15-hydroxyprostaglandin dehydrogenase expression in A549 human lung adenocarcinoma cells. Year Published: 2006
Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky Lexington, KY 40536-0082, USA.
4. Urinary prostaglandin F2alpha is generated from the isoprostane pathway and not the cyclooxygenase in humans. Year Published: 2007
Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University, Nashville, TN 37232, USA.
5. Pioglitazone and rosiglitazone decrease prostaglandin E2 in non-small-cell lung cancer cells by up-regulating 15-hydroxyprostaglandin dehydrogenase. Year Published: 2007
Department of Medicine, Division of Pulmonary, Lung Cancer Research Program and Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California 90095-1690, USA. shazra@mednet.ucla.edu
6. Inhibition of epidermal growth factor receptor signaling elevates 15-hydroxyprostaglandin dehydrogenase in non-small-cell lung cancer. Year Published: 2007
Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, USA.
7. Activation of thromboxane receptor alpha induces expression of cyclooxygenase-2 through multiple signaling pathways in A549 human lung adenocarcinoma cells. Year Published: 2007
Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, KY 40536-0082, United States; College of Pharmacy, Jilin University, Changchun, China.
8. Activation of extracellular signal-regulated kinase by 12-hydroxyheptadecatrienoic acid in prostate cancer PC3 cells. Year Published: 2007
Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, KY 40536-0082, USA.
9. Activation of extracellular signal-regulated kinase by 12-hydroxyheptadecatrienoic acid in prostate cancer PC3 cells. Year Published: 2007
Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, KY 40536-0082, USA.
10. Preterm Birth without Progesterone Withdrawal in 15-Hydroxyprostaglandin Dehydrogenase Hypomorphic Mice. Year Published: 2007
Washington University School of Medicine, 660 South Euclid Avenue, Box 8208, St. Louis, Missouri 63110. Muglia_L@kids.wustl.edu.
11. 15-Hydroxyprostaglandin dehydrogenase protein expression in human fetal membranes with and without subclinical inflammation. Year Published: 2007
Department of Obstetrics and Gynecology, University of Toronto and Mount Sinai Hospital, Toronto, Ontario, Canada.
12. Preterm birth without progesterone withdrawal in 15-hydroxyprostaglandin dehydrogenase hypomorphic mice. Year Published: 2007
Washington University School of Medicine, St. Louis, Missouri 63110, USA.
13. Activation of thromboxane receptor alpha induces expression of cyclooxygenase-2 through multiple signaling pathways in A549 human lung adenocarcinoma cells. Year Published: 2007
Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, KY 40536-0082, United States.